Abstract

Highly sulfated oligosaccharides in the form of hexasaccharide and octasaccharide compounds which have antiproliferative activity with respect to smooth muscle cells are useful in treatment of conditions characterized by unwanted smooth muscle cell proliferation such as a result of trauma or disease states such as asthma, congestive heart failure and hypertension. The oligosaccharides have increased ability to inhibit the proliferation of smooth muscle cells and decreased ability to act as an anticoagulant as compared with commercial heparin and/or unseparated fragments of heparin.

Other References

• Benitz, William, "Inhibition by Heparin of Proliferation of Vascular Smooth Muscle Cells," in A. P. Fishman, "The Pulmonary Circulation: Normal and Abnormal", published 1988 by University of Pennsylvania Press (Philadelphia, Pa., USA), pp. 1-30
• Austin et al., "Intimal Proliferation of Smooth Muscle Cells as an Explanation for Recurrent Coronary Artery Stenosis After Percutaneous Transluminal Coronary Angioplasty,"J. Am. Coll. Cardiol., (1985), 6(2):369-375
• Guo et Conrad, "Analysis of Oligosaccharides from Heparin by Reversed-Phase Ion-Pairing High-Performance Liquid Chromatography," Analy. Biochem., (1988), 168:54-62
• Clowes and Karnowsky, "Suppression by Heparin of Smooth Muscle Cell Proliferation in Injured Arteries," Nature, (1977), 265:625-626
• Marcum et al., "Heparan Sulfate Species and Blood Vessel Wall Function," Biology of Proteoglycans, (1987), Academic Press, pp. 301-343
• Castellot, Jr., et al., "Inhibition of Vascular Smooth Muscle Cell Growth by Endothelial Cell-derived Heparin," J. Biol. Chem., (1982), 257:11256-11260
• Benitz et al., "Heparin Inhibits Proliferation of Fetal Vascular Smooth Muscle Cells in the Absence of Platelet-Derived Growth Factor," J. Cell. Physiol., (1986), 127:1-7
• Orlidge and D'Amore, "Cell Specific Effects of Glycosaminoglycans on the Attachment and Proliferation of Vascular Wall Components," Microvascular Res., (1986), 31:41-53
• Benitz, "The Pulmonary Circulation: Normal and Abnormal," Fishman, A. P., ed., University of Pennsylvania Press, (1988)
• Castellot, Jr., et al., "Structural Determinants of the Capacity of Heparin to Inhibit the Proliferation of Vascular Smooth Muscle Cells," J. Cell. Physiol., (1984), 120:315-320
• Castellot, Jr.; et al., "Structural Determinants of the Capacity of Heparin to Inhibit the Proliferation of Vascular Smooth Muscle Cells. II. Evidence for Pentasaccharide Sequence That Contains a 3-O-Sulfate Group" J. Cell. Biol., (1986), 102:1979-1984
• Barzu et al., "Heparin-Derived Oligosaccharides: Affinity for Acidic Fibroblast Growth Factor and Effect on Its Growth-Promoting Activity for Human Endothelial Cells," J. Cell. Physiol., (1989), 140:538-548
• Wright, Jr., et al., "Structural Determinants of Heparin's Growth Inhibitory Activity," J. Biol. Chem., (1989), 264(3):1534-1542
• Casu, B., "Strucuture and Biological Activity of Heparin," Adv. Carbohydrate Chem. & Biochem., (1985), 43:51-135
• Scott-Burden et al., "Artherosclerosis and Heparinoid-Matrix Interactions," TIPS, (1988), 9:95-97
• Pejler et al., "Monoclonal Antibodies Specific for Oligosaccharides Prepared by Partial Nitrous Acid Deamination of Heparin," J. Biol. Chem., (1988), 263(11):5197-5201
• Conrad, H., "Structure of Heparan Sulfate and Dermatan Sulfate," Heparin and Related Polysaccharides, (1989), 556:18-28
• International (PCT) Search Report, International Application No. PCT/US89/0555